Tempest Therapeutics Inc. (TPST)
NASDAQ · Healthcare
Tempest Therapeutics Inc. Operating Income 2013–2017
Tempest Therapeutics Inc. annual/quarterly operating income history and growth rate from 2013 to 2018. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Tempest Therapeutics Inc. operating income for the quarter ending September 30, 2018 was -7.8 M, a 17.01% decrease year-over-year.
- Tempest Therapeutics Inc. operating income for the twelve months ending September 30, 2018 was -26.6 M, a 61.87% decrease year-over-year.
- Tempest Therapeutics Inc. annual operating income for 2017 was -84.3 M, a 4.09% increase from 2016.
- Tempest Therapeutics Inc. annual operating income for 2016 was -81.0 M, a 12.52% increase from 2015.
- Tempest Therapeutics Inc. annual operating income for 2015 was -72.0 M, a 50.21% increase from 2014.
- Tempest Therapeutics Inc. annual operating income for 2014 was -47.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Tempest Therapeutics Inc. Operating Income — FAQ
Tempest Therapeutics Inc. (TPST) operating income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Tempest Therapeutics Inc.'s operating income?
Tempest Therapeutics Inc. (TPST) reported operating income of -$84M for fiscal 2017.
Where can I see TPST's operating income history?
The chart and table above show Tempest Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.